These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

102 related items for PubMed ID: 16426929

  • 1. CD4+/CD56+ hematologic malignancy with rearranged MLL gene.
    Leung R, Chow EE, Au WY, Chow C, Kwong YL, Lin SY, Ma ES, Wan TS, Wong KF.
    Hum Pathol; 2006 Feb; 37(2):247-9. PubMed ID: 16426929
    [No Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3. An Infant With Congenital Leukemia Cutis and AML-M5 With MLL Gene Rearrangement.
    Bayhan T, Çiki K, Tavil B, Gümrük F, Çetin M, Ünal Ş.
    J Pediatr Hematol Oncol; 2015 Oct; 37(7):566-7. PubMed ID: 26207776
    [No Abstract] [Full Text] [Related]

  • 4. Expression of NG2 antigen in MLL-rearranged acute leukemias: how complex does it get?
    Menendez P, Bueno C.
    Leuk Res; 2011 Aug; 35(8):989-90. PubMed ID: 21492935
    [No Abstract] [Full Text] [Related]

  • 5. Pharmacological inhibition of LSD1 for the treatment of MLL-rearranged leukemia.
    Feng Z, Yao Y, Zhou C, Chen F, Wu F, Wei L, Liu W, Dong S, Redell M, Mo Q, Song Y.
    J Hematol Oncol; 2016 Mar 12; 9():24. PubMed ID: 26970896
    [Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7. Bilateral ovarian B-lineage lymphoblastic lymphoma with MLL gene rearrangement: a novel case in infancy.
    Larish AM, Dolan M, Casey T, Perkins JL.
    J Pediatr Hematol Oncol; 2015 May 12; 37(4):e215-7. PubMed ID: 25493458
    [Abstract] [Full Text] [Related]

  • 8. Neural cell adhesion molecule (CD56)-positive acute myelogenous leukemia and myelodysplastic and myeloproliferative syndromes.
    Mann KP, DeCastro CM, Liu J, Moore JO, Bigner SH, Traweek ST.
    Am J Clin Pathol; 1997 Jun 12; 107(6):653-60. PubMed ID: 9169661
    [Abstract] [Full Text] [Related]

  • 9. In focus: MLL-rearranged leukemia.
    de Boer J, Walf-Vorderwülbecke V, Williams O.
    Leukemia; 2013 Jun 12; 27(6):1224-8. PubMed ID: 23515098
    [Abstract] [Full Text] [Related]

  • 10. Monozygotic twins with non-Down syndrome associated MLL-rearranged hematologic malignancy and megakaryoblastic differentiation.
    Foster JH, Williams CL, Elghetany MT, Liu P, Krance RA, Bertuch AA, Gramatges MM.
    Leuk Lymphoma; 2019 Apr 12; 60(4):1083-1086. PubMed ID: 30277109
    [No Abstract] [Full Text] [Related]

  • 11. Relapsed infant MLL-rearranged acute lymphoblastic leukemia with additional genetic alterations.
    Ishida H, Kanamitsu K, Washio K, Muraoka M, Sakakibara K, Matsubara T, Kanzaki H, Shimada A.
    Pediatr Blood Cancer; 2016 Nov 12; 63(11):2059-60. PubMed ID: 27322816
    [No Abstract] [Full Text] [Related]

  • 12. Spontaneous reversion of a lineage switch following an initial blinatumomab-induced ALL-to-AML switch in MLL-rearranged infant ALL.
    Wölfl M, Rasche M, Eyrich M, Schmid R, Reinhardt D, Schlegel PG.
    Blood Adv; 2018 Jun 26; 2(12):1382-1385. PubMed ID: 29898879
    [Abstract] [Full Text] [Related]

  • 13. A role for DOT1L in MLL-rearranged leukemias.
    Bernt KM, Armstrong SA.
    Epigenomics; 2011 Dec 26; 3(6):667-70. PubMed ID: 22126283
    [No Abstract] [Full Text] [Related]

  • 14. MLL-rearranged mixed phenotype acute leukemia masquerading as B-cell ALL.
    Yang W, Tran P, Khan Z, Rezk S, O'Brien S.
    Leuk Lymphoma; 2017 Jun 26; 58(6):1498-1501. PubMed ID: 27774846
    [No Abstract] [Full Text] [Related]

  • 15. The potential of clofarabine in MLL-rearranged infant acute lymphoblastic leukaemia.
    Stumpel DJ, Schneider P, Pieters R, Stam RW.
    Eur J Cancer; 2015 Sep 26; 51(14):2008-21. PubMed ID: 26188848
    [Abstract] [Full Text] [Related]

  • 16. Validation of NG2 antigen in identifying BP-ALL patients with MLL rearrangements using qualitative and quantitative flow cytometry: a prospective study.
    Zangrando A, Intini F, te Kronnie G, Basso G.
    Leukemia; 2008 Apr 26; 22(4):858-61. PubMed ID: 17851550
    [No Abstract] [Full Text] [Related]

  • 17. MLL-rearranged acute myeloid leukemia: Influence of the genetic partner in allo-HSCT response and prognostic factor of MLL 3' region mRNA expression.
    Burillo-Sanz S, Morales-Camacho RM, Caballero-Velázquez T, Carrillo E, Sánchez J, Pérez-López O, Pérez de Soto I, González Campos J, Prats-Martín C, Bernal R, Vargas MT.
    Eur J Haematol; 2018 May 26; 100(5):436-443. PubMed ID: 29384595
    [Abstract] [Full Text] [Related]

  • 18. MLL-rearrangement can resemble acute promyelocytic leukemia.
    Zhang X, Huang X, Xu H, Li J, Yu W.
    Leuk Lymphoma; 2019 Nov 26; 60(11):2841-2843. PubMed ID: 31038019
    [No Abstract] [Full Text] [Related]

  • 19. Trametinib inhibits RAS-mutant MLL-rearranged acute lymphoblastic leukemia at specific niche sites and reduces ERK phosphorylation in vivo.
    Kerstjens M, Pinhancos SS, Castro PG, Schneider P, Wander P, Pieters R, Stam RW.
    Haematologica; 2018 Apr 26; 103(4):e147-e150. PubMed ID: 29419436
    [No Abstract] [Full Text] [Related]

  • 20. Unusual profiles of pediatric acute lymphoblastic leukemia with MLL gene rearrangement.
    Kubicka M, Soszynska K, Mucha B, Rafinska B, Kolodziej B, Haus O, Styczynski J.
    Leuk Lymphoma; 2007 Oct 26; 48(10):2083-6. PubMed ID: 17917979
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 6.